bioRxiv · 20 Nov 2026
A GPNMB-associated lysosomal program tracks neurodegeneration across the DAM continuum
Georg Wernerh-index 11, Jonas Schulte-Schrepping, Ramona Rodde, Johannes Gnaerich, Elena De Domenico, Georg Kislinger, Karsten Nalbach, Lina Dinkel, Johannes C.M. Schlachetzki, Selina Hummel, Astrid F. Feiten, Patricia Hoffelner, Brigitte Nuscher, Marvin Reich, Inaki Paris, Samira Parhizkar, Alessio Colombo, Stephan A. Mueller, Michael Willem, Sven Lammich, Christian Schrader, Jannis B. Spintge, Danilo Prtvar, Alessio Ricci, Stefan Roth, Matthew J., Todd Logan, Benedikt Wefers, Wolfgang Wurst, Regina Feederle, Arthur Liesz, Dieter Edbauer, Marc D. Beyer, Antje Grosche, Kohichi Kawahara, Christopher Glass, Gilbert Di, Sabina Tahirovic, Stefan F. Lichtenthaler, Mikael Simons, Martina Schifferer, Matthias Brendel, Christian Haass, Anja Capell, Joachim L. Schultze
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Frontotemporal dementia (FTD) and Alzheimer's disease (AD) profoundly remodel microglial states, yet how the heterogeneity of disease-associated microglia (DAM) relates to neurodegeneration remains incompletely understood. Using a progranulin (PGRN) and TMEM106B-deficient mouse model recapitulating key features of frontotemporal lobar degeneration (FTLD), including lysosomal impairment, we demonstrated that CSF1R inhibition reduced microgliosis yet accelerated neurodegeneration, suggesting a protective microglia contribution under lysosomal stress. Single-cell transcriptomics revealed that increasing Gpnmb expression within DAM was associated with a shift from immune and inflammatory processes toward a lysosomal, autolysosomal, and lipid-catabolic program. Across disease models, engagement of the GPNMB-associated program correlated with neurodegeneration. Consistently, A{beta}-driven models with limited neurodegeneration exhibited prominent DAM activation but comparatively limited GPNMB expression and engagement of this program. The GPNMB-associated program was TREM2-dependent, while loss of TREM2 signaling under lysosomal stress was associated with exacerbated neuronal damage. Conversely, lysosomal rescue markedly reduced the GPNMB-associated program, demonstrating its reversibility. CSF proteomics identified a convergent lysosomal and microglial signature across models overlapping with alterations reported in human FTD. Together, GPNMB marks reversible, TREM2-regulated lysosomal transcriptional adaptation along the DAM continuum that scales with lysosomal burden and neurodegenerative severity, consistent with a potentially protective microglial response under lysosomal stress.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Georg Werner has the highest h-index among the authors (11).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.